Ultragenyx Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 7.30 M | $152.93 M | 10.07% | 7.40% |
| 05/08/2026 | 5.39 M | $112.84 M | 100.00% | 5.46% | |
| STATE STREET CORP | 05/15/2026 | 5.02 M | $105.20 M | 16.70% | 5.09% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 4.58 M | $95.91 M | 236.50% | 4.64% |
| 05/15/2026 | 4.19 M | $87.78 M | 100.00% | 4.25% | |
| RTW INVESTMENTS, LP | 05/15/2026 | 3.65 M | $76.44 M | 21.62% | 3.70% |
| SANDS CAPITAL MANAGEMENT, LLC | 05/08/2026 | 3.21 M | $67.34 M | -7.78% | 3.26% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 3.15 M | $65.91 M | 3,676.58% | 3.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 2.64 M | $55.33 M | 7.27% | 2.68% |
| BELLEVUE GROUP AG | 05/15/2026 | 2.38 M | $49.86 M | 92,148.06% | 2.41% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 2.26 M | $47.30 M | 1,030.42% | 2.29% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 2.21 M | $46.21 M | 420.18% | 2.24% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2026 | 2.19 M | $45.91 M | 11.51% | 2.22% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.12 M | $44.32 M | -9.06% | 2.15% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.85 M | $38.75 M | 0.61% | 1.88% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.77 M | $37.13 M | 101.24% | 1.80% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 1.62 M | $33.84 M | 17.45% | 1.64% |
| MORGAN STANLEY | 05/15/2026 | 1.50 M | $31.44 M | -17.84% | 1.52% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2026 | 1.43 M | $29.98 M | -18.19% | 1.45% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 1.43 M | $29.89 M | 121.78% | 1.45% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.26 M | $26.42 M | 265.76% | 1.28% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 1.22 M | $25.53 M | -3.82% | 1.24% |
| 05/14/2026 | 1.17 M | $24.42 M | 100.00% | 1.18% | |
| CANDRIAM S.C.A. | 04/30/2026 | 1.10 M | $22.97 M | 37.13% | 1.11% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.05 M | $21.93 M | -13.79% | 1.06% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 914.76 K | $19.16 M | 100.00% | 0.93% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 893.30 K | $18.71 M | 100.00% | 0.91% |
| EAGLE HEALTH INVESTMENTS LP | 05/15/2026 | 884.12 K | $18.52 M | 100.00% | 0.90% |
| CATALIO CAPITAL MANAGEMENT, LP | 05/15/2026 | 850.80 K | $17.82 M | 423.41% | 0.86% |
| UBS GROUP AG | 05/05/2026 | 832.74 K | $17.45 M | 24.51% | 0.84% |
| SPHERA FUNDS MANAGEMENT LTD. | 05/15/2026 | 809.33 K | $16.96 M | 169.22% | 0.82% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 804.11 K | $16.85 M | -48.27% | 0.82% |
| NUVEEN, LLC | 04/30/2026 | 662.05 K | $13.87 M | -17.40% | 0.67% |
| HRT FINANCIAL LP | 05/14/2026 | 613.23 K | $12.85 M | 22.24% | 0.62% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 608.22 K | $12.74 M | 100.00% | 0.62% |
| PICTET ASSET MANAGEMENT HOLDING SA | 04/22/2026 | 603.57 K | $11.67 M | -50.98% | 0.61% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 596.50 K | $12.50 M | 29.31% | 0.61% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 590.29 K | $12.36 M | 43.53% | 0.60% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 561.70 K | $11.77 M | 53.43% | 0.57% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 558.49 K | $11.70 M | -6.75% | 0.57% |
| NORTHERN TRUST CORP | 05/14/2026 | 535.57 K | $11.22 M | 1.69% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 524.80 K | $10.99 M | 244.55% | 0.53% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 504.14 K | $10.56 M | 334.88% | 0.51% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 500.92 K | $10.49 M | 89.84% | 0.51% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 494.74 K | $10.36 M | -33.29% | 0.50% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 490.78 K | $10.28 M | -45.65% | 0.50% |
| IKARIAN CAPITAL, LLC | 05/15/2026 | 482.57 K | $10.11 M | 3,708.47% | 0.49% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 480.00 K | $10.06 M | 71.43% | 0.49% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2026 | 451.12 K | $9.45 M | 36.22% | 0.46% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 444.54 K | $9.31 M | 13.81% | 0.45% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ultragenyx Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 428 institutional investors and hedge funds held shares of Ultragenyx Pharmaceutical Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 7.3 M
STATE STREET CORP: 5.02 M
AQR CAPITAL MANAGEMENT LLC: 4.58 M
RTW INVESTMENTS, LP: 3.65 M
SANDS CAPITAL MANAGEMENT, LLC: 3.21 M
Sofinnova Investments, Inc.: 3.15 M
99.50% of Ultragenyx Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 113.44 M shares in the last 24 months. This purchase volume represents approximately $2.56 B in transactions.